Inovio Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Inovio Pharmaceuticals

15/11/2024 14:03

* Inovio Pharmaceuticals Inc  INO.OQ  reported a quarterly
adjusted loss of 89 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of $-1.56.  The mean expectation of
six analysts for the quarter was for a loss of $1.15 per share.
Wall Street expected results to range from $-1.24 to -94 cents
per share.
    * Reported revenue was zero​; analysts expected $104.50
thousand. 
    * Inovio Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 89 cents​.
    * The company reported a quarterly loss of $25.17 million.
    * Inovio Pharmaceuticals Inc shares had fallen by 17.5% this
quarter and lost 22.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Inovio
Pharmaceuticals Inc is 13.50 
This summary was machine generated from LSEG data November 15 at
02:03 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.15          -0.89          Beat
 Jun. 30 2024      -1.10          -1.19          Missed
 Mar. 31 2024      -1.00          -1.31          Missed
 Dec. 31 2023      -1.27          -1.12          Beat